PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsrheumatoid arthritis
MeSH D001172 - rheumatoid arthritis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D001327:Autoimmune diseases
1 Company
1 Drug
$
Success rate
D001168:Arthritis
15 Companies
8 Drugs
$
Success rate
D012216:Rheumatic diseases
178 Companies
34 Drugs
$
Success rate
D001172: 
Rheumatoid arthritis
227 Companies
82 Drugs
$
Success rate
D005258:Felty syndrome
0 Companies
0 Drugs
Success rate
D012859:Sjogren's syndrome
0 Companies
0 Drugs
Success rate
D016706:Adult-onset still's disease
0 Companies
0 Drugs
Success rate
D056653:Rheumatoid vasculitis
0 Companies
0 Drugs
Success rate
D002205:Caplan syndrome
0 Companies
0 Drugs
Success rate
D012218:Rheumatoid nodule
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyAspirin, Methocarbamol Robaxisal  1982-01-01   
AAIPharmaAzathioprine Azasan  1999-06-07   
Aspirin, Propoxyphene napsylate Darvon-n W/ Asa  1982-01-01   
Abbott BiotherapeuticsAdalimumab Trudexa  2003-09-01   
Aspirin, Hydrocodone Vicoprin  1983-09-14   
Ibuprofen Ibu  1989-12-18   
Ibuprofen Ibuprofen  1985-06-14   
AbbVieAdalimumab Humira  2002-12-31 $6,210 M Q3/24-Q2/25 
Upadacitinib Rinvoq 2031-01-15 2019-08-16 $7,194 M Q3/24-Q2/25 
Ibuprofen, Hydrocodone Vicoprofen  1997-09-23   
Cyclosporine Cyclosporine  2000-03-03   
Cyclosporine Gengraf  2000-05-12   
Cyclosporine Restasis Multidose 2024-08-27 2002-12-23 $224 M Y2024 
Able LaboratoriesNaproxen Naproxen  2003-08-22   
Accord HealthcareMethotrexate Methotrexate  2007-04-30   
Hydroxychloroquine Hydroxychloroquine  2020-04-07   
ACIC PharmaceuticalsCelecoxib Celecoxib  2020-12-09   
Aet PharmaLeflunomide Leflunomide  2021-05-10   
Ajanta PharmaTofacitinib Tofacitinib  2021-06-01   
Esomeprazole, Naproxen Naproxen Esomeprazole Magnesium  2022-10-06   
Alembic PharmaceuticalsMethotrexate Methotrexate  2024-06-03   
Celecoxib Celecoxib  2015-08-21   
Diclofenac Diclofenac  2022-07-27   
Leflunomide Leflunomide  2011-11-21   
1
2
3
4
5
6
...
23
>
Clinical Trials
Historical Success Rate
Phase 1
64%
72/113
Phase 2
47%
61/130
Phase 3
75%
119/158
Approved: 63Overall Success rate: 23%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Adalimumab,
Aspirin,
Ibuprofen,
Hydrocodone,
Ibuprofen lysine,
Alfacalcidol,
Bevifimod,
Globulin, immune,
Fluzone,
Pneumovax,
Histone-arginine methyltransferase carm1,
Flumist,
Surlorian,
Flucelvax,
Prevenar
AbbVie
Adalimumab,
Upadacitinib,
Cyclosporine,
Glucosamine,
Lutikizumab,
Aspartame,
Bevifimod,
ELSUBRUTINIB,
RAVAGALIMAB,
REMTOLUMAB,
TREGALIZUMAB,
Globulin, immune,
Streptococcus pneumoniae polysaccharide conjugated to corynebacterium diphtheriae crm197,
Prevnar13,
Pcv13,
Pneumovax,
Prevenar
Allergan
Aspirin,
Codeine,
Diclofenac,
Diclofenac epolamine,
Esomeprazole,
Ibuprofen,
Ibuprofen lysine,
Indomethacin,
Nabumetone,
Oxycodone
1
2
3
4
5
6
...
16
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use